BackView on Congress.gov
119th Congress•House

HRES. 803

Committee

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Latest action
2025-10-10
Referred to the House Committee on Energy and Commerce.
Introduced
2025-10-10
Cosponsors
11
Origin
House
Subjects
Health

Key actions

  1. 2025-10-10IntroReferral
    Submitted in House
  2. 2025-10-10IntroReferral
    Referred to the House Committee on Energy and Commerce.
  3. 2025-10-10IntroReferral
    Submitted in House

Bill text versions

Related bills

No related bills listed.